Oxidative stress regulation of stem and progenitor cells

Antioxidants and Redox Signaling

Volumn 11, Issue 11, 2009, Pages 2777-2789

  Pervaiz, Shazib ^a,b,c,d   Taneja, Reshma ^a,b,e   Ghaffari, Saghi ^e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SINGAPORE MIT ALLIANCE   (Singapore)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; FREE RADICAL; TRANSCRIPTION FACTOR FOXO; REACTIVE OXYGEN METABOLITE;

CANCER CELL; CELL ACTIVITY; CELL FATE; CELL REGENERATION; ELECTRON TRANSPORT; HEMATOPOIETIC TISSUE; HUMAN; INTRACELLULAR SIGNALING; MITOCHONDRION; MUSCLE DISEASE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; HEMATOPOIETIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 70350685238     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2804     Document Type: Review

References (134)

1. Ahmad KA, ClementMV,and Pervaiz S. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxideinduced apoptosis. Ann N Y Acad Sci 1010: 365-373, 2003.
2. Ahmad KA, Iskandar KB, Hirpara JL, Clement MV, and Pervaiz S. Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res 64: 7867-7878, 2004.
3. Akram S, Teong HF, Fliegel L, Pervaiz S, and Clement MV. Reactive oxygen species-mediated regulation of the Naα-Hα exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers. Cell Death Differ 13: 628-641, 2006.
4. Babior BM. NADPH oxidase: an update. Blood 93: 1464-1476, 1999.
5. Balon TW and Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77: 2519-2521, 1994.
6. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, and Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171, 1996.
7. Bartek J, Bartkova J, and Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773-7779, 2007.
8. Barzilai A, Rotman G, and Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 1: 3-25, 2002.
9. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
10. Berneske GM, Butson AR, Gauld EN, and Levy D. Clinical trial of high dosage vitamin E in human muscular dystrophy. Can Med Assoc J 82: 418-421, 1960.
11. Binder HJ, Herting DC, Hurst V, Finch SC, and Spiro HM. Tocopherol deficiency in man. N Engl J Med 273: 1289-1297, 1965.
12. Blake DJ, Weir A, Newey SE, and Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329, 2002.
13. Brenman JE, Chao DS, Xia H, Aldape K, and Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743-752, 1995.
14. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, and Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015, 2004.
15. Burdon RH. Control of cell proliferation by reactive oxygen species. Biochem Soc Trans 24: 1028-1032, 1996.
16. Chang TS, Cho CS, Park S, Yu S, Kang SW, and Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 279: 41975-41984, 2004.
17. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG, and Stull JT. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A 93: 9142-9147, 1996.
18. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, and Zheng P. TSC-MTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205: 2397-2408, 2008.
19. Chen ZX and Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ 14: 1617-1627, 2007.
20. Clement MV, Hirpara JL, and Pervaiz S. Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria. Cell Death Differ 10: 1273-1285, 2003.
21. Clement MV and Pervaiz S. Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death. Redox Rep 6: 211-214, 2001.
22. Clement MV, Ponton A, and Pervaiz S. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 440: 13-18, 1998.
23. Clement MV and Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 15: 216-225, 1996.
24. Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM, and Campbell KP. mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 7: 823-829, 1998.
25. Davies KE and Nowak KJ. Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol 7: 762-773, 2006.
26. Davies KJ, Quintanilha AT, Brooks GA, and Packer L. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107: 1198-1205, 1982.
27. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, and Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780-783, 2009.
28. Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA, and Rando TA. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 161: 77-84, 1998.
29. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
30. Ervasti JM and Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121-1131, 1991.
31. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, and Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308: 1181-1184, 2005.
32. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT 3rd, Park JH, Provine MA, Florence J, Kaiser KK, King WM, Pandya S, Robison J, and Signore L. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 11: 1164-1168, 1988.
33. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A, Miranda M, Mari M, Ardite E, and Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 273: G7-G17, 1997.
34. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
35. Gebre-Medhin M, Gustavson KH, Gamstorp I, and Plantin LO. Selenium supplementation in X-linked muscular dystrophy: effects on erythrocyte and serum selenium and on erythrocyte glutathione peroxidase activity. Acta Paediatr Scand 74: 886-890, 1985.
36. Gong MC, Arbogast S, Guo Z, Mathenia J, Su W, and Reid MB. Calcium-independent phospholipase A2 modulates cytosolic oxidant activity and contractile function in murine skeletal muscle cells. J Appl Physiol 100: 399-405, 2006.
37. Guzy RD and Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91: 807-819, 2006.
38. Halliwell B and Gutteridge J. Free radicals in biology and medicine. New York: Oxford University Press, 1999.
39. Halliwell B and Gutteridge JMC. Free radicals in biology and medicine. Oxford, England: Clarendon Press, 2007.
40. Hamelin M, Sayd T, Chambon C, Bouix J, Bibe B, Milenkovic D, Leveziel H, Georges M, Clop A, Marinova P, and Laville E. Differential expression of sarcoplasmic proteins in four heterogeneous ovine skeletal muscles. Proteomics 7: 271-280, 2007.
41. Hasegawa A, Suzuki S, Matsumoto Y, and Okubo T. In vivo fatiguing contraction of rat diaphragm produces hydroxyl radicals. Free Radic Biol Med 22: 349-354, 1997.
42. Henderson LM and Chappel JB. NADPH oxidase of neutrophils. Biochim Biophys Acta 1273: 87-107, 1996.
43. Higuchi M, Cartier LJ, Chen M, and Holloszy JO. Superoxide dismutase and catalase in skeletal muscle: adaptive response to exercise. J Gerontol 40: 281-286, 1985.
44. Hirpara JL, Clement MV, and Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 276: 514-521, 2001.
45. Hoffman EP, Brown RH Jr, and Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987.
46. Iiyama M, Kakihana K, Kurosu T, and Miura O. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell Signal 18: 174-182, 2006.
47. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
48. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997-1002, 2004.
49. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, and Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446-451, 2006.
50. Jang YY and Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110: 3056-3063, 2007.
51. Jenkins RR. Free radical chemistry: relationship to exercise. Sports Med 5: 156-170, 1988.
52. Ji LL, Fu R, and Mitchell EW. Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity. J Appl Physiol 73: 1854-1859, 1992.
53. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, and Sattler M. Activation of the PI3K=mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 105: 1717-1723, 2005.
54. Kobzik L, Reid MB, Bredt DS, and Stamler JS. Nitric oxide in skeletal muscle. Nature 372: 546-548, 1994.
55. Kobzik L, Stringer B, Balligand JL, Reid MB, and Stamler JS. Endothelial type nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 211: 375-381, 1995.
56. Kolbeck RC, She ZW, Callahan LA, and NosekTM. Increased superoxide production during fatigue in the perfused rat diaphragm. Am J Respir Crit Care Med 156: 140-145, 1997.
57. Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, and Skorski T. BCR= ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 108: 319-327, 2006.
58. Kozlov AV, Szalay L, Umar F, Kropik K, Staniek K, Niedermuller H, Bahrami S, and Nohl H. Skeletal muscles, heart, and lung are the main sources of oxygen radicals in old rats. Biochim Biophys Acta 1740: 382-389, 2005.
59. Kumar AP, Chang MK, Fliegel L, Pervaiz S, and Clement MV. Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity. Cell Death Differ 10: 1733-1746, 2007.
60. Laughlin MH, Simpson T, Sexton WL, Brown OR, Smith JK, and Korthuis RJ. Skeletal muscle oxidative capacity, antioxidant enzymes, and exercise training. J Appl Physiol 68: 2337-2343, 1990.
61. Lawler JM and Powers SK. Oxidative stress, antioxidant status, and the contracting diaphragm. Can J Appl Physiol 23: 23-55, 1998.
62. Lee TH, Kim SU, Yu SL, Kim SH, Park do S, Moon HB, Dho SH, Kwon KS, Kwon HJ, Han YH, Jeong S, Kang SW, Shin HS, Lee KK, Rhee SG, and Yu DY. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101: 5033-5038, 2003.
63. Leeuwenburgh C, Fiebig R, Chandwaney R, and Ji LL. Aging and exercise training in skeletal muscle: responses of glutathione and antioxidant enzyme systems. Am J Physiol 267: R439-R445, 1994.
64. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, and Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001, 2006.
65. Libina N, Berman JR, and Kenyon C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115: 489-502, 2003. (Pubitemid 37456810)
66. Lim S and Clement MV. Phosphorylation of the survival kinase Akt by superoxide is dependent on an ascorbatereversible oxidation of PTEN. Free Radic Biol Med 42: 1178-1192, 2007.
67. Lin K, Dorman JB, Rodan A, and Kenyon C. daf-16: An HNF-3=forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322, 1997.
68. Lin K, Hsin H, Libina N, and Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin= IGF-1 and germline signaling. Nat Genet 28: 139-145, 2001.
69. Lin SJ, Defossez PA, and Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128, 2000.
70. Marinkovic D, Zhang X, Yalcin S, Luciano JP, Brugnara C, Huber T, and Ghaffari S. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest 117: 2133-2144, 2007.
71. Matsuo Y, Nishinaka Y, Suzuki S, Kojima M, Kizaka-Kondoh S, Kondo N, Son A, Sakakura-Nishiyama J, Yamaguchi Y, Masutani H, Ishii Y, and Yodoi J. TMX, a human transmembrane oxidoreductase of the thioredoxin family: the possible role in disulfide-linked protein folding in the endoplasmic reticulum. Arch Biochem Biophys 423: 81-87, 2004.
72. Matsushima Y, Nanri H, Nara S, Okufuji T, Ohta M, Hachisuka K, and Ikeda M. Hindlimb unloading decreases thioredoxin-related antioxidant proteins and increases thioredoxin-binding protein-2 in rat skeletal muscle. Free Radic Res 40: 715-722, 2006.
73. McArdle A, Edwards RH, and Jackson MJ. How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromuscul Disord 5: 445-456, 1995.
74. Meng TC, Buckley DA, Galic S, Tiganis T, and Tonks NK. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem 279: 37716-37725, 2004.
75. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
76. Miyamoto K, Araki KY, Naka K, Arai F, Tabuko K, Yamazaki S, Matsuoka S, Miyamoto T, Ito K, Ohmura M, Chen C, Hosokawa K, Nakauchi H, Nakayama K, Nakayama KI, Harada M, Motayama N, Suda T, and Hirao A. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1: 101-112, 2007.
77. Murakami S and Johnson TE. The OLD-1 positive regulator of longevity and stress resistance is under DAF-16 regulation in Caenorhabditis elegans. Curr Biol 11: 1517-1523, 2001.
78. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, and Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277-283, 2003.
79. Murphy ME and Kehrer JP. Oxidative stress and muscular dystrophy. Chem Biol Interact 69: 101-173, 1989.
80. Nagayasu H, Hamada J, Kawano T, Konaka S, Nakata D, Shibata T, Arisue M, Hosokawa M, Takeichi N, and Moriuchi T. Inhibitory effects of malotilate on invasion and metastasis of rat mammary carcinoma cells by modifying the functions of vascular endothelial cells. Br J Cancer 77: 1371-1377, 1998.
81. Nethery D, Stofan D, Callahan L, DiMarco A, and Supinski G. Formation of reactive oxygen species by the contracting diaphragm is PLA(2) dependent. J Appl Physiol 87: 792-800, 1999. (Pubitemid 29375018)
82. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, and Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458-470, 2008.
83. O'Neill CA, Stebbins CL, Bonigut S, Halliwell B, and Longhurst JC. Production of hydroxyl radicals in contracting skeletal muscle of cats. J Appl Physiol 81: 1197-1206, 1996.
84. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, and Ruvkun G. The Forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999, 1997.
85. Ookuma S, Fukuda M, and Nishida E. Identification of a DAF-16 transcriptional target gene, scl-1, that regulates longevity and stress resistance in Caenorhabditis elegans. Curr Biol 13: 427-431, 2003.
86. Orrenius S, Gogvadze V, and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47: 143-183, 2007.
87. Pattwell DM, McArdle A, Morgan JE, Patridge TA, and Jackson MJ. Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells. Free Radic Biol Med 37: 1064-1072, 2004.
88. Pervaiz S, Cao J, Chao OS, Chin YY, and Clement MV. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene 20: 6263-6268, 2001.
89. Peter Y, Rotman G, Lotem J, Elson A, Shiloh Y, and Groner Y. Elevated Cu=Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice. EMBO J 20: 1538-1546, 2001.
90. Petrof BJ. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 81: S162-S174, 2002.
91. Pillai SR, Traber MG, Kayden HJ, Cox NR, Toivio-Kinnucan M, Wright JC, Braund KG, Whitley RD, Gilger BC, and Steiss JE. Concomitant brainstem axonal dystrophy and necrotizing myopathy in vitamin E-deficient rats. J Neurol Sci 123: 64-73, 1994.
92. Powers SK, Criswell D, Lawler J, Ji LL, Martin D, Herb RA, and Dudley G. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol 266: R375-R380, 1994.
93. Rando TA. Oxidative stress and the pathogenesis of muscular dystrophies. Am J Phys Med Rehabil 81: S175-S186, 2002.
94. Rando TA, Disatnik MH, Yu Y, and Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 8: 14-21, 1998.
95. Reid MB. Invited review: redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol 90: 724-731, 2001.
96. Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, and West MS. Reactive oxygen in skeletal muscle, I: intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 73: 1797 -1804, 1992.
97. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, and Weissman IL. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414, 2003.
98. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
99. Rhee SG, Yang KS, Kang SW, Woo HA, and Chang TS. Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal 7: 619-626, 2005.
100. Rivera A and Maxwell S.A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurindependent pathway. J Biol Chem 280: 29346-29354, 2005.
101. Roelofs RI, de Arango GS, Law PK, Kinsman D, Buchanan DC, and Park JH. Treatment of Duchenne's muscular dystrophy with penicillamine: results of a double-blind trial. Arch Neurol 36: 266-268, 1979.
102. Rowland LP. Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve 3: 3-20, 1980.
103. Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T, Greenfield EA, Salgia R, and Griffin JD. The BCR=ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 275: 24273-24278, 2000.
104. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, and Griffin JD. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93: 2928-2935, 1999.
105. Savitsky PA and Finkel T. Redox regulation of Cdc25C. J Biol Chem 277: 20535-20540, 2002.
106. Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol 79: 675-686, 1995.
107. Seo JH, Ahn Y, Lee SR, Yeol Yeo C, and Chung Hur K. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase=Akt pathway. Mol Biol Cell 16: 348-357, 2005.
108. Shenoy K, Wu Y, and Pervaiz S. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors. Cancer Res 69: 1941-1950, 2009.
109. Stern LZ, Ringel SP, Ziter FA, Menander-Huber KB, Ionasescu V, Pellegrino RJ, and Snyder RD. Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol 39: 342-346, 1982.
110. Sun H, Li L, Vercherat C, Gulbagci NT, Acharjee S, Li J, Chung TK, Thin TH, and Taneja R. Stra13 regulates satellite cell activation by antagonizing Notch signaling. J Cell Biol 177: 647-657, 2007.
111. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
112. Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG, and Kanakura Y. E2F1 and c-Myc potentiate apoptosis through inhibition of NFkappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9: 1017-1029, 2002.
113. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
114. Tidball JG and Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102: 1677-1686, 2007.
115. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegue E, Depinho RA, and Gilliland DG. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339, 2007.
116. Tsai WB, Chung YM, Takahashi Y, Xu Z, and Hu MC. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 10: 460-467, 2008.
117. Turner PR, Westwood T, Regen CM, and Steinhardt RA. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335: 735-738, 1988.
118. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, and Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031-1044, 2002.
119. Vasilaki A, Csete M, Pye D, Lee S, Palomero J, McArdle F, Van Remmen H, Richardson A, McArdle A, Faulkner JA, and Jackson MJ. Genetic modification of the manganese superoxide dismutase=glutathione peroxidase 1 pathway influences intracellular ROS generation in quiescent, but not contracting, skeletal muscle cells. Free Radic Biol Med 41: 1719-1725, 2006.
120. Vercherat C, Chung T-K, Yalcin S, Gulbagci N, Gopinadhan S, Ghaffari S, and Taneja R. Stra13 is required for the regulation of oxidative stress mediated skeletal muscle degeneration. Hum Mol Genet 2009 Aug 13. [Epub ahead of print].
121. Vrbova G. Duchenne dystrophy viewed as a disturbance of nerve-muscle interactions. Muscle Nerve 6: 671-675, 1983.
122. Walton JN and Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 77: 169-231, 1954.
123. Wang L, Azad N, Kongkaneramit L, Chen F, Lu Y, Jiang BH, and Rojanasakul Y. The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation. J Immunol 180: 3072-3080, 2008.
124. Webster C, Silberstein L, Hays AP, and Blau HM. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513, 1988.
125. Wehling M, Spencer MJ, and Tidball JG. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155: 123-131, 2001.
126. Whitehead NP, Pham C, Gervasio OL, and Allen DG. NAcetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586: 2003-2014, 2008.
127. Wolff S, Ma H, Burch D, Maciel GA, Hunter T, and Dillin A. SMK-1, an essential regulator of DAF-16-mediated longevity. Cell 124: 1039-1053, 2006.
128. Yalcin S, Marinkovic D, Zhang X, Mungamuri K, Tong W, Cullen DE, and Ghaffari S. Oxidative stress-mediated amplification of AKT=mTOR signaling pathway leads to myeloproliferative syndrome in FoxO3 null mice. Blood 112: 509, 2008.
129. Yalcin S, Zhang X, Luciano JP, Mungamuri SK, Marinkovic D, Vercherat C, Sarkar A, Grisotto M, Taneja R, and Ghaffari S. Foxo3 Is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 283: 25692-25705, 2008.
130. Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H, and Nakauchi H. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 25: 3515-3523, 2006.
131. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, and Morrison SJ. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475-482, 2006. (Pubitemid 44050144)
132. You H and Mak TW. Crosstalk between p53 and FOXO transcription factors. Cell Cycle 4: 37-38, 2005.
133. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, and Li L. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518-522, 2006.
134. Zhu QS, Xia L, Mills GB, Lowell CA, Touw IP, and Corey SJ. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 107: 1847-1856, 2006.